ClinicalTrials.gg
Status unknownNCT05823454Updated Aug 1, 2024

Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness

An observational study in Consciousness Disorder, sponsored by Beijing Tiantan Hospital. Status unknown at 1 site in China. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-08-01.

Sponsored by Beijing Tiantan Hospital · Observational

The sponsor has not verified this record recently (last verified Jul 2024), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
200
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Consciousness-specific Brain Network Connection of Propofol Sedation and Prolonged Disorders of Consciousness based on Electroencephalography and Auditory Event-related Potentials

02

Conditions studied

  • Consciousness Disorder

Keywords

  • Prolonged Disorders of Consciousness
  • Propofol
  • Brain Functional connectivity
  • Electroencephalography
03

In context

Consciousness Disorders

244 studies on the registry are indexed under Consciousness Disorders; 104 are open to participants now.

This study's planned enrollment of 200 is above the median of 79 across 86 observational studies indexed under Consciousness Disorders.

Browse Consciousness Disorders studies →

Lead sponsor

Beijing Tiantan Hospital is the lead sponsor of 481 studies on the registry; 287 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Patients with chronic disorders of consciousness

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 - 65 years old, native Chinese speaker, dextromanuality;
  • Chronic disorder of consciousness;
  • Spinal cord electrical stimulator implantation under general anesthesia;
  • Signed informed consent.

Exclusion criteria

Exclusion Criteria:

  • Continuous sedation was administered within 72 hours prior to the study;
  • Open head injury, parenchymatectomy and other damage of brain structural integrity;
  • The intracranial compliance decreased due to hydrocephalus and swelling;
  • Known hearing impairment;
  • Airway stenosis and various causes of severe ventilation or ventilation dysfunction;
  • Known or suspected cardiac dysfunction;
  • Allergic to intravenous general anesthetics;
  • Associated with other mental or neurological diseases;
  • Other reasons are not suitable to participate in this study.
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
200 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes

Groups and cohorts

  • Propofol

    Intravenous infusion

    Drug: Different drug dosage

  • Dexmedetomidine

    Intravenous infusion

    Drug: Different drug dosage

  • Esketamine

    Intravenous infusion

    Drug: Different drug dosage

  • Sevoflurane

    Inhalation anesthesia

    Drug: Different drug dosage

  • Remifentanil

    Intravenous infusion

    Drug: Different drug dosage

Interventions

  • DrugDifferent drug dosage

    Choice of Anesthesia

06

What researchers measure

Primary outcomes

  1. EEG Spectral Characteristics

    Characteristics of EEG power spectrum(for 1-30 Hz) in patients with chronic consciousness disorder under different doses of drugs

    Time frame: During the trial(up to 3 hours for each subject)

Secondary outcomes

  1. Cortical Connectivity

    Characteristics of the weighted phase lag index in patients with chronic consciousness

    Time frame: During the trial(up to 3 hours for each subject)

  2. Derived quantitative indicators

    Characteristics of EEG derived quantitative indicators with chronic consciousness disorder during anesthesia recovery

    Time frame: During the trial(up to 3 hours for each subject)

  3. Characteristics of sleep

    Characteristics of sleep cycle in patients with chronic disorders of consciousness

    Time frame: During the trial(up to 24 hours for each subject)

  4. Dynamic Patterns of Cortical Connectivity

    The time-frequency characteristics of the weighted phase lag index in patients with chronic disorders of consciousness

    Time frame: During the trial(up to 3 hours for each subject)

  5. Rate of patients recovered consciousness after surgery

    Rate of patients recovered consciousness 30 days, 90 days, 180 days after surgery

    Time frame: During the trial(through study completion, 180 days)

07

Study locations

1 of 1 sites recruiting
  • Beijing Tiantan Hospital, Capital Medical University
    Beijing, 100070, China
    • Ruquan Han, M.D., Ph.D · Contact · ruquan.han@gmail.com · 8610-59976660
    • Ruquan Han, M.D., Ph.D · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05823454
Responsible party
Ruquan Han (Professor, Beijing Tiantan Hospital) — Principal investigator
First posted
Apr 21, 2023
Start date
Sep 30, 2022
Primary completion
Sep 1, 2025 (estimated)
Completion
Mar 1, 2026 (estimated)
Last update
Aug 1, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion